Skip to content
Tech News
← Back to articles

Improving access to essential medicines via decision-aware machine learning

read original get AI Medical Diagnostic Tool → more articles
Why This Matters

This article highlights the transformative potential of decision-aware machine learning in enhancing access to essential medicines, particularly in developing countries. By leveraging advanced algorithms, the healthcare industry can optimize supply chains, improve demand forecasting, and address persistent challenges in medicine availability and affordability, ultimately benefiting consumers and health systems alike.

Key Takeaways

Yadav, P. Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform. Health Syst. Reform 1, 142–154 (2015).

UNICEF. The State of the World’s Children 2015: Executive Summary (UN, 2015).

Gallien, J., Leung, N.-H. Z. & Yadav, P. Inventory policies for pharmaceutical distribution in Zambia: improving availability and access equity. Prod. Oper. Manag. 30, 4501–4521 (2021).

Merkuryeva, G., Valberga, A. & Smirnov, A. Demand forecasting in pharmaceutical supply chains: a case study. Procedia Comput. Sci. 149, 3–10 (2019).

Yenet, A., Nibret, G. & Tegegne, B. A. Challenges to the availability and affordability of essential medicines in African countries: a scoping review. Clin. Outcomes Res. 15, 443–458 (2023).

De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat. Med. 24, 1342–1350 (2018).

Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med. 25, 24–29 (2019).

Ngiam, K. Y. & Khor, W. Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 20, e262–e273 (2019).

Bastani, H. et al. Efficient and targeted COVID-19 border testing via reinforcement learning. Nature 599, 108–113 (2021).

Yang, X. et al. A large language model for electronic health records. npj Digit. Med. 5, 194 (2022).

... continue reading